1. Home
  2. PRPO vs KXIN Comparison

PRPO vs KXIN Comparison

Compare PRPO & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • KXIN
  • Stock Information
  • Founded
  • PRPO N/A
  • KXIN 2015
  • Country
  • PRPO United States
  • KXIN China
  • Employees
  • PRPO N/A
  • KXIN N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • KXIN Retail-Auto Dealers and Gas Stations
  • Sector
  • PRPO Industrials
  • KXIN Consumer Discretionary
  • Exchange
  • PRPO Nasdaq
  • KXIN Nasdaq
  • Market Cap
  • PRPO 8.8M
  • KXIN 9.2M
  • IPO Year
  • PRPO N/A
  • KXIN N/A
  • Fundamental
  • Price
  • PRPO $4.69
  • KXIN $0.13
  • Analyst Decision
  • PRPO
  • KXIN
  • Analyst Count
  • PRPO 0
  • KXIN 0
  • Target Price
  • PRPO N/A
  • KXIN N/A
  • AVG Volume (30 Days)
  • PRPO 5.6K
  • KXIN 2.0M
  • Earning Date
  • PRPO 08-15-2024
  • KXIN 11-26-2019
  • Dividend Yield
  • PRPO N/A
  • KXIN N/A
  • EPS Growth
  • PRPO N/A
  • KXIN N/A
  • EPS
  • PRPO N/A
  • KXIN N/A
  • Revenue
  • PRPO $15,812,000.00
  • KXIN $31,535,000.00
  • Revenue This Year
  • PRPO $75.18
  • KXIN N/A
  • Revenue Next Year
  • PRPO N/A
  • KXIN N/A
  • P/E Ratio
  • PRPO N/A
  • KXIN N/A
  • Revenue Growth
  • PRPO 61.64
  • KXIN N/A
  • 52 Week Low
  • PRPO $4.65
  • KXIN $0.11
  • 52 Week High
  • PRPO $8.99
  • KXIN $5.52
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 34.21
  • KXIN 42.66
  • Support Level
  • PRPO $4.73
  • KXIN $0.13
  • Resistance Level
  • PRPO $5.14
  • KXIN $0.16
  • Average True Range (ATR)
  • PRPO 0.34
  • KXIN 0.01
  • MACD
  • PRPO -0.02
  • KXIN -0.00
  • Stochastic Oscillator
  • PRPO 31.40
  • KXIN 10.81

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

Share on Social Networks: